Overview of the Safety of Felodipine Based on Clinical Trials in Patients With Hypertension
Author/Authors :
Welin، نويسنده , , Lennart and Elvelin، نويسنده , , Lars and Niklasson، نويسنده , , Anne-Mari Olsson، نويسنده , , Gunnar and Elmfeldt، نويسنده , , Dag، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1997
Pages :
4
From page :
996
To page :
999
Abstract :
All clinical studies of at least 1 weekʹs duration with felodipine in patients with hypertension were included in a safety analysis. The major finding was that felodipine does not increase mortality or the incidence of major cardiovascular events and that the data indicate a favorable effect.
